OBJECTIVES The aim of this study was to investigate the frequency and clinical implications of a delayed echocardiographic response to cardiac resynchronization therapy (CRT).
C ardiac resynchronization therapy (CRT) is an established treatment for select patients with symptomatic heart failure (HF) with reduced ejection fraction (EF) and a prolonged QRS complex (1, 2) . In these patients, CRT alleviates symptoms, improves left ventricular (LV) size and systolic function, reduces hospitalizations, and improves survival. When the response to CRT is assessed according to echocardiography after 6 to 12 months of therapy, approximately 30% to 40% of patients do not seem to respond favorably, depending on the specific criteria used to define response (3) . Patients who have increases in EF $5 units or decreases in LV volume $15% within this time frame reportedly also exhibit improved morbidity and mortality compared with patients whose response does not meet these thresholds (4) (5) (6) (7) .
A few studies have examined the time course of improvements in LV size and function after the initiation of CRT, and they found that most of the From the *United Heart & Vascular Clinic, Allina Health, St. Paul, Minnesota; and the yDepartment of Biomedical Engineering, echocardiographic evidence regarding CRT response is present after 6 to 12 months of therapy (8) (9) (10) . Other studies, however, have noted that a minority of patients exhibit a slower, delayed positive response (11, 12) . To the best of our knowledge, this subgroup of CRT patients has not been previously examined in detail. The prevalence of delayed CRT response is not well established; the impact of this response on clinical endpoints such as survival or hospitalizations has also not been well established.
The main purpose of the present study was to investigate mid-term and long-term changes in LV size and function in a large consecutive cohort of CRT patients to assess for delayed response to therapy. We were particularly interested in patients with a delayed therapeutic response. We also investigated the effects of a delayed response on clinical outcomes of mortality and hospitalization for HF. Changes in ESV (-27 AE 48 ml vs. Burns et al.
Baseline demographic and echocardiographic analysis of the 3 patient groups is presented in Table 2 . Echocardiographic characteristics of each group at baseline, mid-term, and long-term follow-up are summarized in Figure 2 . In the study group as a whole, both EF ( Figure 2A ) and ESV ( Figure 2B) improved most from the pre-CRT baseline to the mid- LONG-TERM CLINICAL RESPONSE. Kaplan-Meier curves comparing all-cause mortality in the 3 study groups are presented in Figure 3A , and unadjusted and adjusted Cox proportional hazards model analyses are presented in Table 3 . Beginning 3 years after CRT device implantation, 49 (17%) of the subjects Kaplan-Meier curves comparing the combined outcome of HF hospitalizations or death in the 3 study groups are presented in Figure 3B , and the results of unadjusted and adjusted Cox proportional hazards model analyses are presented in Table 3 . After CRT device implantation, 95 (32%) of the subjects met the combined endpoint, at a rate of 6% per year. Burns et al.
A few previous studies have reported the time course of echocardiographic reverse remodeling after CRT (9, 10) . In a study of 313 CRT patients who were followed up for 3.5 years, Verhaert et al. (10) found that the rate of change in left ventricular end-systolic volume (LVESV) was 10 times greater during the first 6 months of therapy than it was thereafter. Similarly, in a long-term echocardiographic follow-up of the CARE-HF (Cardiac Resynchronization-Heart Failure)
trial, LVESV decreased and EF increased rapidly in the first 9 months, and more slowly for the remainder of the follow-up period (9). Our results are similar.
We found that, on average, both LVESV and EF improved rapidly in the first year and more slowly thereafter. We also investigated individual differences in the time course of reverse remodeling after CRT. A significant subset of patients exhibited a delayed response, which was not evident when examining the mean response of the entire study group.
Isolated reports of delayed response to CRT have been described previously. Castellant et al. (11) found that 11 of the 84 CRT patients in their study experienced full normalization of EF at long-term followup; in 2 of the 11, however, no significant changes in EF were detected for the first 18 to 24 months of therapy. In addition, Gasparini et al. (12) reported that approximately 10% of the 520 CRT patients in their study had a normalization of EF that occurred very late in therapy (up to 3 years after implantation).
However, the median follow-up in this study was only 28 months; therefore, the long-term response rate was not well established. Our study used a smaller threshold of response, which has been helpful in predicting long-term outcomes in previous large-scale studies (13) (14) (15) , and we ensured that all patients were followed up for at least 3 years. To our knowledge, our attempt is the first to characterize this phenomenon in a large cohort of patients. percentage of long-term responders with LBBB morphology.
Alternatively, patients with a delayed response to CRT may benefit through a mechanism other than improved mechanical dyssynchrony. We did not investigate diastolic function or neurohormonal factors, but improvements in these areas may have been responsible for a more gradual improvement in LV size and function.
As previously shown in other studies, we found that mid-term responders in the present study tended to have more prolonged QRS durations, a lower incidence of ischemic disease, and more frequent LBBB patterns on electrocardiogram than nonresponders (7, 16, 20) . However, long-term responders and nonresponders did not differ in these or the other variables measured.
Our center is aggressive in optimizing the device settings of CRT nonresponders (24, 25) . In addition, as a retrospective study, we relied on hospital records and online obituaries to determine mortality. Although it is possible that our search process missed some hospitalizations or deaths, we expect that any underreporting of these events would be of small magnitude and would be similar between the study groups. Also, because this was a retrospective study, not all data of interest were available for many subjects (e.g., biomarker data, Future prospective studies should include these measurements. Finally, due to the relatively small number of long-term responders in this study, it was impossible to identify the demographic or echocardiographic factors that may predict delayed response in CRT patients.
CONCLUSIONS
Among patients who survive at least 3 years after undergoing CRT device implantation with echocardiographic follow-up, 43% of nonresponders at 1-year follow-up experienced a delayed echocardiographic response after $3 years of therapy.
Survival and hospitalizations were similar for all echocardiographic responders, regardless of the time at which the response occurred. As a result, the echocardiographic response rate among those surviving 3 years after CRT device implantation was 77%. Values are hazard ratio (95% confidence interval). The adjusted models include sex, age at implantation, left bundle branch block, ischemic disease, atrial fibrillation, right ventricular dysfunction, QRS duration, ejection fraction and end-systolic volume, serum creatinine, beta-blocker usage, and angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker usage.
